Papers

1

Total Citations

2

H-Index

1

About

Yafei Xu is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly through robotic-assisted approaches. His most notable contribution is the development and validation of uniportal robotic lobectomy and lymphadenectomy for invasive lung cancer, a novel approach that challenges the conventional multiport robotic-assisted thoracoscopic surgery (mRATS). In his landmark 2024 study, Xu meticulously evaluated the safety and feasibility of this technique, demonstrating its potential to reduce surgical trauma while maintaining oncologic efficacy. Although his work is still emerging, with his key paper currently accumulating 2 citations, Xu’s research addresses a critical gap in robotic thoracic surgery by providing the first comprehensive perioperative outcomes for uniportal robotic procedures. His findings offer a promising alternative that could reshape surgical standards, making lung cancer resections less invasive and more accessible. As a researcher committed to innovation in surgical oncology, Xu’s work holds significant implications for improving patient recovery and quality of life, positioning him as a rising authority in the field of robotic thoracic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Uniportal Robotic Lobectomy and Lymphadenectomy for Invasive Lung Cancer: A Novel Approach and Perioperative Outcomes
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago